Imago BioSciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
August 12, 2022 at 04:05 pm EDT
Imago BioSciences, Inc. reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported net loss was USD 13.74 million compared to USD 8.81 million a year ago. Basic loss per share from continuing operations was USD 0.41 compared to USD 8.13 a year ago.
For the six months, net loss was USD 30.14 million compared to USD 15.92 million a year ago. Basic loss per share from continuing operations was USD 0.89 compared to USD 15.06 a year ago.